Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Fracture Dislocation of Ankle Joint: later-stage trial registry

1 of 1 indexed Fracture Dislocation of Ankle Joint trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Fracture Dislocation of Ankle Joint: 1 US clinical trial tracked, 1 recruiting.

Fracture Dislocation of Ankle Joint is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is George Washington University, running 1 of these trials.

Enrollment posture brief

Registry condition fracture-dislocation-of-ankle-joint

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Fracture Dislocation of (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Fracture Dislocation of Ankle Joint

Fracture Dislocation of Ankle Joint lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fracture Dislocation of Ankle Joint on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fracture Dislocation of Ankle Joint is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Fracture Dislocation of Ankle Joint records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Exparel + Bupivacaine Drug
1 trials
Bupivacaine Drug
1 trials

US sites by state

Facility locations filed on Fracture Dislocation of Ankle Joint trials. A trial with sites in several states counts in each.

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fracture Dislocation of Ankle Joint page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Fracture Dislocation of Ankle Joint trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • George Washington University sponsors the most Fracture Dislocation of Ankle Joint trials on record, review their full trial history before evaluating a specific study. See George Washington University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fracture Dislocation of Ankle Joint condition card totals 1 registered trials; most-linked intervention Exparel + Bupivacaine; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.